Icon

XANAX (nda018276)- (0.25MG,0.5MG,1MG,2MG)

ALPRAZOLAM UPJOHN
0.25MG,0.5MG,1MG,2MG
Yes No
2002-Sep-16 Expired
None None
None No
XANAX is a benzodiazepine indicated for the:  Acute treatment of generalized anxiety disorder in adults.  Treatment of panic disorder with or without agoraphobia in adults.
10 0 8
Total Other Developers 1
Drugs with Suitability Yes
0.25MG ** ** - 4 -
0.5MG ** ** Up - 4
1MG ** ** - 4 -
2MG ** ** Up - 4
NDA Sales Available Total Generic Sales Available
Yes 5
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******** ****** ******** ****** *** *********** ** **** *****, **** *******, *** ****** (**) *****, ****** ****** (***) ***
****** ******* ********* **** ************** ********** ***. *********** ** *** ******* ******, ********** ****, **** ****, *******, ****** (***) ***
****** ******* ********* ******* ********* *** *********** *** ****** ***, *********, *** ****** (**) *****, ****** ****** (***) ***
****** ***** ***** ****** ******* *********** ****** ********, ******, **********, ********* *** ***, ***** (***) ***
****** ********* ****** ********* ****** ******* *********** ****-***, ** **. ***/*, ***/*, ***/*, ***/* & ***/*, **** ** **** ***, *****, ***** ********** ****, *********, ********* ******, ************, ********* ******, ***** (***) ***
****** ********* ** ******* *************** ******* ******* *********** **** **. *, ************* ******* ****, *****-**, *********, ****, *********** ******, ***** (***) ***
****** ********* ** ******* *************** ******* ******* *********** **** ** **, **** ********** ******, ***** **, ****, ******, *** ******, ***** (***) ***
****** ******* ********* ****** ****** ******* ******* *********** **** **. **-*-*, ***** ** ***** ********** ******, *****, ********, *** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.